AMBALALSA vs GAUDIUMIVF: Stock Comparison

Ambalal Sarabhai Enterprises Ltd vs Gaudium IVF and Women Health LtdUpdated 20 Aug 26, 4:08 PM ISTNSE & company filings

Gaudium IVF and Women Health Ltd is the larger company by market capitalisation. Ambalal Sarabhai Enterprises Ltd shows a lower P/E, while Gaudium IVF and Women Health Ltd shows a higher ROE, lower leverage and a higher ROCE. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

AMBALALSA leads 2; GAUDIUMIVF leads 8 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

AMBALALSAGAUDIUMIVF

Valuation lens

What price are you paying?

Market CapContext only
₹338 Cr
₹844 Cr
P/E RatioAMBALALSA has the lower reading
27.1x
35.97x
P/B RatioAMBALALSA has the lower reading
2.22x
5.78x
EPSGAUDIUMIVF has the higher reading
₹2.32
₹3.12
Book ValueContext only
₹20.7
₹0
Dividend YieldSame reading
0%
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
GAUDIUMIVF is the larger company
₹844 Cr vs ₹338 Cr
P/E Ratio
AMBALALSA has a lower P/E
27.1x vs 35.97x
P/B Ratio
AMBALALSA has a lower P/B
2.22x vs 5.78x
EPS
GAUDIUMIVF has higher earnings per share
₹3.12 vs ₹2.32
Qtr Sales Growth
GAUDIUMIVF has stronger quarterly sales growth
56.2% vs 1.05%
Qtr Profit Growth
GAUDIUMIVF has stronger quarterly profit growth
53.7% vs 13.4%
ROE
GAUDIUMIVF has a higher ROE
16.08% vs 12.4%
ROCE
GAUDIUMIVF has a higher ROCE
48.6% vs 11.5%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Price

MetricAMBALALSAGAUDIUMIVF
Live Price₹47.74₹128.17
Day Change3.07%3.04%
Volume2.46 L11.51 L
52-Week High₹49.98₹133
52-Week Low₹30.15₹69.18
Distance from 52W High-4.48%-3.63%

Valuation

MetricAMBALALSAGAUDIUMIVF
Market Cap₹338 Cr₹844 Cr
P/E Ratio27.1x35.97x
P/B Ratio2.22x5.78x
EPS₹2.32₹3.12
Book Value₹20.7₹0
Dividend Yield0%0%

Growth

MetricAMBALALSAGAUDIUMIVF
Revenue Growth (TTM YoY)0%0%
EPS Growth (TTM YoY)0%0%
Qtr Sales Growth1.05%56.2%
Qtr Profit Growth13.4%53.7%

Profitability & Leverage

MetricAMBALALSAGAUDIUMIVF
ROE12.4%16.08%
ROCE11.5%48.6%
Net Margin8.8%23.47%
Operating Margin5.82%34.2%
Debt to Equity0.36x0.15x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricAMBALALSAGAUDIUMIVF
Promoter Holding31.36%71.29%
FII Holding0%3.02% 3.68 pp
DII Holding0.01%2.22% 0.4 pp
Public Holding68.64%23.47% 4.08 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Ambalal Sarabhai Enterprises Ltd and Gaudium IVF and Women Health Ltd.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.